Surgeon General releases a Call to Action on Hypertension

The office of the Surgeon General releases a call to action recommending that hypertension control become a national public health priority, optimizing patient care, and building a community to help control high blood pressure. Progress made in controlling hypertension “is slipping away from us”, said, U.S. Surgeon General Jerome M. Adams, MD, MPH. This leaves…

Read More

Esperion Announces Commercial Availability of NEXLIZET™ (bempedoic acid and ezetimibe) Tablets and Ushers in New Era of Oral Combination Medicine for LDL-Cholesterol Lowering

– First-Ever Non-Statin Combination Medicine, Providing 38 Percent Mean LDL-C Lowering –– Esperion Aims to Set New Industry Standard by Pricing NEXLIZET for Patient Affordability and Access with Minimal to No Paperwork Requirements for Health Care Providers –– Launch Date Accelerated by One Month at Health Care Providers Request – ANN ARBOR, Mich., June 04, 2020 (GLOBE NEWSWIRE)…

Read More